- Home
- GOOS vs DYN Comparison
GOOS vs DYN Comparison
Compare GOOS & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOOS
- DYN
- Stock Information
- Founded
- GOOS 1957
- DYN 1984
- Country
- GOOS Canada
- DYN United States
- Employees
- GOOS N/A
- DYN 192
- Industry
- GOOS
- DYN Medicinal Chemicals and Botanical Products
- Sector
- GOOS
- DYN Health Care
- Exchange
- GOOS Nasdaq
- DYN Nasdaq
- Market Cap
- GOOS 1.1B
- DYN 1.2B
- IPO Year
- GOOS 2017
- DYN 2020
- Fundamental
- Price
- GOOS $14.04
- DYN $9.07
- Analyst Decision
- GOOS Hold
- DYN Strong Buy
- Analyst Count
- GOOS 5
- DYN 15
- Target Price
- GOOS $11.25
- DYN $43.07
- AVG Volume (30 Days)
- GOOS 1.1M
- DYN 3.4M
- Earning Date
- GOOS 07-31-2025
- DYN 08-11-2025
- Dividend Yield
- GOOS N/A
- DYN N/A
- EPS Growth
- GOOS 70.17
- DYN N/A
- EPS
- GOOS 0.68
- DYN N/A
- Revenue
- GOOS $943,742,214.00
- DYN N/A
- Revenue This Year
- GOOS $4.27
- DYN N/A
- Revenue Next Year
- GOOS $5.83
- DYN N/A
- P/E Ratio
- GOOS $20.64
- DYN N/A
- Revenue Growth
- GOOS 1.09
- DYN N/A
- 52 Week Low
- GOOS $6.73
- DYN $6.36
- 52 Week High
- GOOS $14.33
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- GOOS 75.78
- DYN 45.47
- Support Level
- GOOS $13.74
- DYN $8.25
- Resistance Level
- GOOS $14.13
- DYN $9.83
- Average True Range (ATR)
- GOOS 0.49
- DYN 0.56
- MACD
- GOOS 0.15
- DYN 0.14
- Stochastic Oscillator
- GOOS 99.29
- DYN 74.80
About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.